Moon, T.H.; Jo, G.H.; Seo, E.J.; Kim, K.T.; Ku, E.J.; Kwon, S.K.; Kim, J.Y.; Chae, J.B.; Kim, D.Y.
Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients. J. Clin. Med. 2022, 11, 7047.
https://doi.org/10.3390/jcm11237047
AMA Style
Moon TH, Jo GH, Seo EJ, Kim KT, Ku EJ, Kwon SK, Kim JY, Chae JB, Kim DY.
Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients. Journal of Clinical Medicine. 2022; 11(23):7047.
https://doi.org/10.3390/jcm11237047
Chicago/Turabian Style
Moon, Tae Hwan, Gwon Hui Jo, Eoi Jong Seo, Kyung Tae Kim, Eu Jeong Ku, Soon Kil Kwon, Jin Young Kim, Ju Byung Chae, and Dong Yoon Kim.
2022. "Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients" Journal of Clinical Medicine 11, no. 23: 7047.
https://doi.org/10.3390/jcm11237047
APA Style
Moon, T. H., Jo, G. H., Seo, E. J., Kim, K. T., Ku, E. J., Kwon, S. K., Kim, J. Y., Chae, J. B., & Kim, D. Y.
(2022). Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients. Journal of Clinical Medicine, 11(23), 7047.
https://doi.org/10.3390/jcm11237047
